Cyclic AMP-phosphodiesterase is present in various mouse fibroblasts. Contact-inhibited 3T3 cells contain two forms of the enzyme, one with a Km of 2.5 uIM and the second with a Km of 71 AM. As 3T3 cells grow to confluency and cAMP concentrations rise, the activity of the first enzyme increases, whereas that of the second is unchanged. A line of SV40-transformed 3T3 cells with low cAMP concentrations also has low levels of the cAMPphosphodiesterase with a K,,, of 2.5 1AM. Treatment of 3T3 and SV40-transformed 3T3 cells with dibutyryl cAMP and theophylline increases cAMP-phosphodiesterase accumulation. This accumulation is blocked by cycloheximide and actinomycin D. The newly formed enzyme resembles the higher affinity enzyme present in unstimulated cells, since it has a Km of 1.2-2.0 MM, and is stimulated by snake venom. In L cells in which cAMP concentrations are elevated by treatment with prostaglandin El, cAMP phosphodiesterase also accumulates. We conclude that intracellular concentrations of cAMP regulate the synthesis of cAMP-phosphodiesterase, and that cAMP functions as an inducer of the enzyme.
Previous studies indicated that cAMP regulates the growth, morphology, and adhesiveness of normal and transformed fibroblasts (1) (2) (3) (4) . Thus, an understanding of cAMP metabolism is important to elucidate the regulation of these properties in normal and cancer cells. cAMP concentrations are determined by the activity of the enzyme adenylate cyclase, which catalyzes the formation of cAMP from ATP, and cAMP phosphodiesterase, which degrades cAMP into 5'-AMP (for review, see ref. 5) . cAMP can also leak from cells into the extracellular fluid. We have previously reported on the properties of adenylate cyclase in normal and transformed fibroblasts (4) . Here, we report on the properties of the cAMP phosphodiesterase. We find that mouse 3T3 cells have high levels of cAMP phosphodiesterase activity; kinetic analysis, suggests the activity is due to two enzymes. However, one line of SV4O-transformed cells has very low activities of cAMP phosphodiesterase. The total activity of the enzyme is dependent on the intracellular concentration of cAMP, and this activity is increased by treatment of cells with But2cAMP (N6-2'-Odibutyryl cAMP) and theophylline. These findings suggest that cAMP functions as an inducer of the enzyme.
MATERIALS AND METHODS
[3H]cAMP (14.3 Ci/mmole) was obtained from SchwarzMann and purified on Dowex AG 50W-X8 resin. cAMP was also obtained from Schwarz-Mann, snake venom (Ophiophagus hannah) from Sigma Chemical Co., and Dowex 1-X2, 200-400 mesh from Bio-Rad. The resin was washed with 0.5 N NaOH, 0.5 N HCl, and deionized water, to a final pH of 5.0, before use.
Separatipn and Assay of phosphodiesterase. The cells were grown under standard conditions (4) . The cAMP phosphodiesterase was prepared by washing the monolayer four times with ice-cold phosphate-buffered saline (pH 7.4) and four times with ice-cold homogenizing medium containing 0.04 M Tris-HCl (pH 8.0)-10.9% sucrose (w/v). The cells were scraped from the culture dish with a rubber stopper, and homogenized in 0.5-1.0 ml of homogenizing medium, at a final concentration of protein of 2-5 mg/ml, in a glass Dounce homogenizer (tight pestle; 20 strokes). All steps were at 0-4°C. The resulting homogenate was used directly as the enzyme in the assay. Protein measurements were made by the method of Lowry et al. (6) , with bovine serum albumin as the standard. The assay for cAMP phosphodiesterase was essentially the two-step assay of Butcher and Sutherland (7) , with snake venom used in the second step as a source of 5'-nucleotidase to convert the product of cAMP phosphodiesterase (i.e., 5'-AMP) to adenosine and inorganic phosphate.
In the first stage, the 0.18-ml reaction mixture contained 40 mM Tris HCl (pH 8), 10 over a range of 5-250 j&g/ml. In each assay not more than 15-20% of the substrate was consumed. The relative velocity was expressed in nmol of cAMP hydrolyzed per mg of protein per min at 30'C. All of the experiments were repeated from 3 to 5 times, and each experimental value represents the mean of two or three closely agreeing numbers.
RESULTS
Kinetic analysis of the cAMP phosphodiesterase activity in 3T34 cells by double-reciprocal plots is shown in Fig. 1A and B. We find that these cells, like many tissues of the rat (9), (Fig. 1B) . The presence of snake venom seems to slightly decrease the activity of this second enzyme. Table 1 shows the increase in the cAMP phosphodiesterase activity during growth of 3T34 cells. When these cells become contact-inhibited, the cAMP phosphodiesterase activity rises from 3-to 5-fold. This rise is present in both the low-and the high-Km enzymes, and occurs whether the enzyme is measured in the presence or in the absence of venom. The apparent Km values, however, seem to be unchanged. We found that when 3T3-4 cells become contact-inhibited, the intracellular concentration of cAMP rises by about 3 to 4-fold (3). Therefore, it seems likely that cAMP itself is the inducer of the cAMP phosphodiesterase.
To test this possibility, we treated 3T3-4 cells with But2-cAMP and theophylline. The results of these experiments are shown in Table 2 . After 40 hr of treatment with 1.2 mM But2cAMP and 1mM theophylline, the cAMP phosphodiesterase activity is more than doubled.
We have measured cAMP phosphodiesterase activity in various transformed cell lines. One of these lines, transformed by SV40 virus, has quite low concentrations of cAMP. A kinetic analysis of cAMP phosphodiesterase in a crude homogenate of this line (3T3-SV40) is shown in Fig. 2 The rate of accumulation of phosphodiesterase when 3T3-SV40 cells are treated with But2cAMP and theophylline is shown in Fig. 3 . After 46 hr of treatment, there is a 5-fold increase in cAMP phosphodiesterase activity assayed in the presence of venom and an 18-fold increase in activity assayed in its absence. But2cAMP alone is active, but much-less effective in raising cAMP phosphodiesterase activity.
Cycloheximide and actinomycin D completely prevent the induction of cAMP phosphodiesterase (Table 3 ). This result indicates that the effect is dependent on RNA and protein synthesis, and is not simply due to an activation of cAMP phosphodiesterase by But2cAMP and/or theophylline.
Kinetic analysis of the enzyme accumulated after 30 hr of treatment with But2cAMP and theophylline show that it has a Km of 1.5 AM both in the presence and absence of venom. The Vm.s is 70 pmol per mg per min without venom and 160 in its presence. Thus, the enzyme produced appears to resemble the low-Km enzyme present in 3T3 cells containing high concentrations of cAMP. As shown in Fig. IA and B , it is the low-Km enzyme whose activity is stimulated by the addition of venom; the activity of the high-Km enzyme is slightly inhibited. Bovine-brain cAMP phosphodiesterase is resolved into two components during purification by DEAE-chromatography (8) . One component ("catalytic fraction") has low catalytic activity, whereas the other ("activator"), a heat-stable fraction, has no activity. The two components yield fully active enzyme when recombined.
To examine whether we were stimulating the synthesis of an excess of activator, we mixed the enzyme prepared from control and treated cells. The activity obtained is the sum of the two separate activities, indicating that the increase in cAMP phosphodiesterase activity in cells treated with But2cAMP and theophylline is not due to synthesis of an activator (Table  4 ). This experiment also indicates the low cAMP phosphodiesterase activity in the extract of 3T3-SV40 cells does not result from the presence of an inhibitor, but from the presence of smaller amounts of cAMP phosphodiesterase.
Treatment of the purified catalytic fraction from DEAEcellulose with snake venom or trypsin also increases its activity.-Although this activation is not observed with the unpurified brain enzyme (8-10), we found that either venom l/2A~l/2Foud 8 25
The samples shown in Table 3 were mixed as indicated and assayed for activity at 0.625 uM cAMP.
or trypsin markedly increased the activity of the unpurified fibroblast enzyme.
To further examine whether we were preferentially stimulating the synthesis of one or both components of the fully active enzyme, we assayed all our samples in the presence or absence of snake venom. If we were stimulating synthesis of the catalytic subunit, we could expect there to be a preferential stimulation of the activity of the induced enzyme by snake venom, whereas if we were stimulating the synthesis of the activator, we might see less increase in activity by venom treatment. In general, the induced enzyme is somewhat less dependent on stimulation by venom, suggesting some excess of activator subunit.
L-929 cells contain an adenylate cyclase that is activated by prostaglandin E1 (PGE,) (4) ; there is a 6-to 10-fold increase in the cAMP content of the cells when they are incubated with this compound (Otten, Johnson, and Pastan, unpublished results). We find a 20% increase in cAMP phosphodiesterase activity as assayed in the presence of venom and a 30% increase in the enzyme assayed its absence after 24 hr of incubation of L-929 cells with 50 Mg/ml of PGEI.
DISCUSSION
The results presented in this paper show that cAMP phosphodiesterase activity increases when contact-inhibited 3T3-4 cells become confluent, when 3T3-4 and 3T3-SV40 cells are treated with But2cAMP and theophylline, and when L-929 cells are treated with PGE,. These data suggest that the level of activity of cAMP phosphodiesterase is regulated by the intracellular concentration of the substrate, cAMP.
Most of our studies on the synthesis of cAMP phosphodiesterase have been performed with a line of SV40-transformed 3T3 cells, which we previously observed contained low concentrations of cAMP (3). These cells also contain low levels of cAMP phosphodisterase. However, shortly after the addition of But2cAMP and theophylline, the enzyme begins to accumulate; this accumulation continues for about 48 hr, until a plateau value is achieved. Apparently, accumulation requires new RNA and protein synthesis, since treatment with either actinomycin D or cycloheximide prevents enzyme accumulation.
This increase in enzymatic activity could be due to an increase in synthesis of enzyme, a decrease in degradation of enzyme, or conversion from an inactive to an active form. The inhibition by actinomycin D and cycloheximide suggests that accumulation is due to an increase in the rate of synthesis. However, it is possible that the requirement for RNA and protein synthesis reflects a need to synthesize a component that converts inactive cAMP phosphodiesterase to an active form, or that prevents degradation of the enzyme.
Most tissues of rat have at least two cyclic AMP phosphodiesterases, which can be identified kinetically and can be separated by gel filtration (9) . We find in mouse 3T3 cells kinetic evidence for two phosphodiesterases. In the SV40-transformed cells, there is kinetic evidence for only one cAMP phosphodiesterase, with a Km of about 2.5 MM, but the presence of a low level of a second enzyme cannot be excluded.
After treatment of the SV40 cells with But2cAMP and theophylline, the enzyme activity approaches that of 3T3 cells, but there is still kinetic evidence for only one cAMP phosphodiesterase.
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